Arkolith/Insider Trading/RVNC/Form 4

Foley Mark J

CEO, DirectorRevance Therapeutics, Inc. (RVNC) · full profile →Form 4 · filed Mar 19, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2024Tax withholding(F)3K$5.31$18K1.0M
Mar 15, 2024Tax withholding(F)17K$5.31$91K995K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479290-24-000065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML